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Abstract
In external beam radiation therapy (EBRT), the
quality assurance (QA) of the radiation beam is crucial to the
accurate delivery of the prescribed dose to the patient. One of
the dosimetric parameters that require monitoring is the beam
output, specified as the dose rate on the central axis under
reference conditions. The aim of this project was to validate
dose rate calibration of megavoltage photon beams using the
International Atomic Energy Agency (IAEA)/World Health
Organisation (WHO) postal audit dosimetry service. Three
photon beams were audited: a 6 MV beam from the lowenergy linac and 6 and 18 MV beams from a dual high-energy
linac. The agreement between our stated doses and the IAEA
results was within 1% for the two 6 MV beams and within 2%
for the 18 MV beam. The IAEA/WHO postal audit dosimetry
service provides an independent verification of dose rate
calibration protocol by an international facility.
Keywords: Radiation, ERBT, Photon beams.

Introduction
External beam radiation therapy (EBRT) using
megavoltage photon beams from linear accelerators is the
most widely used treatment modality in the treatment of
cancer. The accurate delivery of prescribed dose to the patient
requires vigilant and on-going quality assurance (QA) of
radiation beam dosimetry.1-4 One of the dosimetric
parameters that require monitoring is the beam output,
specified as the dose rate on the central axis under reference
conditions.
The Aga Khan University Hospital (AKUH) radiation
oncology centre in Karachi, Pakistan, has two Varian Clinac®
linear accelerators: a 6 MV and a 6/18 MV dual-energy
machines. The beam outputs of these modalities are
monitored on a daily basis using the PTW-QCPlus®
commercial tool as part of the morning pre-treatment QA.
The daily readings are referenced to the monthly calibrations
in solid water using a Farmer chamber with a calibration
factor traceable to the IAEA/WHO network of Secondary
Standards Dosimetry Laboratory (SSDL) in Islamabad,
Pakistan.5,6 The absolute in-water calibrations are performed
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yearly, following a scheduled annual QA, using the AAPM
TG 51 Protocol.7 The absolute calibrations may be prone to
errors arising from an incorrect experimental setup and/or
incorrect interpretation/application of the dose measurement
protocol. Hence, it would be reassuring to have it verified by
an independent external facility.
Thermoluminescent dosimetry (TLD) remains a
proven and accepted methodology for postal dose audit
service.8-10 Unlike other in-vivo dosimetres such as diodes,
MOSFET and other solid state detectors, TLDs are small,
rugged and re-usable;11,12 they require no connection to an
external electrometer. Hence, they are cost-effective and
ideally suited for remote dose audits. The time delay between
the irradiation and the readout is a necessary consequence of
postal audit system, but this is not an issue.

Materials and Methods
The IAEA/WHO offers a free postal TLD service to
participating institutions to audit dose rate calibrations of
clinical teletherapy photon beams from Cobalt-60 and
megavoltage linear accelerators. Their service can be
requested by correspondence.13 The postal audit service14 is a
three-step process (Table-1): the IAEA mails the irradiation
kit and the instructions to the participating institution; the
institution performs the irradiation within a stated timeframe
and mails back the package for readout; and the results of the
audit are mailed back to the participant.
If the results are within the IAEA acceptance limit of
±5%, a subsequent audit is recommended within two years. If
the results are outside the acceptance limit, the IAEA mails
out a second irradiation package for an immediate repeat
procedure. If the repeat audit does not resolve the
discrepancy, the IAEA recommends an expert's visit to the
institution. In addition to the bi-annual service, the IAEA also
considers individual requests under special circumstances
such as new installations, major repairs or any unusual
clinical considerations.
The IAEA/WHO package consists of a tripod stand, a
hollow plastic holder that attaches to the tripod base plate, TL
capsules and instruction sheets. The TL dosimeter consists of
J Pak Med Assoc

Table-1: Summary of the postal audit activities and timelines.
Activities

Timelines

Explored the venue: “IAEA/WHO
Postal Dose Audit Service”.
Requested IAEA/WHO to include
AKUH as participant.
IAEA/WHO confirmed AKUH registration.

August-October 2009

TL dosimeter received from IAEA along with the irradiation protocol.

November-09

TL dosimeter irradiated as per IAEA/WHO instruction, subsequent to our annual QA
TL dosimeters sent back to IAEA/WHO

December-09

Receipt of results

April-10

Table-2: Summary of the IAEA TLD Audit results for the photon beams at AKUH.
Photon Beams

Varian Clinac®
600 C/D – 6 MV
PDD10 = 67.0%
Varian Clinac®
2300 C/D – 6 MV
PDD10 = 67.0%
Varian Clinac®
2300 C/D –18 MV
PDD10 = 80.0%

TLD
Capsule

IAEA Dose (Gy)
Measured*

Mean

User Stated
Dose** (Gy)

IAEA Mean
User Dose

10462-1

1.94

1.94

1.96

0.99

10462-2
10463-1

1.94
1.96

1.97

1.96
1.98

0.99

10463-2
10464-1

1.97
1.94

1.95

1.98
1.98

0.98

10464-2

1.95

1.98

*: Mean of four readings from each TL capsule. The combined uncertainty in TLD measurement of dose is 1.6% (1 standard deviation).16
**: The combined uncertainty is 1.9%; based on the uncertainty in the user Co-60 calibration factor (1.25%)6 and user high energy photon beam (1.4%).17

~165 mg of LiF powder in a watertight polyethylene 3mm x
20mm cylindrical capsule that allows four readings to be
made from each sample.15 The irradiation kit was assembled
as per the instructions, placed in a water bath (plastic
container) with its top surface in line with the water level and
positioned in such a way that the TL capsule in the holder was
aligned with the central axis of the beam at a depth of 10 cm
(Figure-1). A fixed source-axis distance (SAD) of 100cm and
a 10cm x 10cm field size were used. The irradiation geometry
is shown by the schematic diagram in Figure-2.

three photon beams are shown in Figure-3. If the monthly
reading exceeds the tolerance level of ±2%, the output is tuned
to bring back to its nominal value of 1.0 cGy/MU. The mean
and standard deviations of the results are 0.993±1% for the 6
MV low-energy linac and 1.008±0.5% for 6 and 18 MV beams
from the dual-energy linac. It is interesting to note that the

Three photon beams were audited: a 6 MV beam from
the low-energy linac and 6 and 18 MV beams from a dual
high-energy linac. Each capsule (two per beam) was
irradiated with 200 monitor units (MU) and the dose
delivered, based on our in-house calibration, was noted.
Subsequent to the irradiation, the TLD capsules were repackaged and mailed back to the IAEA for readout.

Results
The agreement between our stated doses and the
IAEA/WHO results was within 1% for the 6 MV beam and
within 2% for the 18 MV beam (Table-2).
The monthly QA results of the dose calibrations for the
Vol. 62, No. 5, May 2012

Figure-1: Irradiation Setup; tripod stand placed in the water container.
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mandatory; namely, an immediate re-audit and, if necessary, a
visit from the IAEA/WHO experts to resolve the discrepancy.
Izewska et. al.16 have carried out an analysis of the
uncertainties in the IAEA/WHO postal audit system. The
absorbed dose determined from the TLD measurements is
expressed as:
DTLD = M * N * f1 * f2 * f3 * f4

Figure2: Schematic diagram showing the TLD irradiation geometry.

(1)

where M is the mean of the four TLD readings from
each capsule and N is the TLD calibration factor. The remaining
factors in Eq. (1) are the TL correction factors for fading
(decrease of TL response due to loss of charge between
irradiation and readout), the influence of the holder
(perturbation effect), energy dependence (due to neutron
contamination in high energy photon beams) and dose response
non-linearity (above 12 Gy), respectively. They estimate the
combined relative standard uncertainty in the DTLD with highenergy X-rays to be 1.6% (1 standard deviation).
The corresponding combined uncertainty in our userstated doses is estimated to be 1.9%. This is based on the
uncertainty in the Co-60 calibration factor (1.25%) for the
Farmer chamber, as stated by the SSDL6; and the uncertainty
in the conversion of the chamber reading to determine the
absorbed dose to water for high-energy photon beams
(1.4%).16 Hence, an agreement between the user-stated dose
and that determined by IAEA/WHO within 2.5%
([1.62+1.92]) would be reasonable. This is in line with the
results of our efforts.

Figure-3: Monthly dose rate calibrations: February 2009 - February 2010.

magnitude of standard deviations speak well for the stability of
the linacs over a one-year period. In fact, the same trend has
been observed over a period of four years for both linacs.

Discussion
The decision to participate in the IAEA/WHO external
audit was taken at the departmental level, involving the
Operational Group consisting of radiation oncologists,
medical physicists, radiation therapists and the Chair of
Quality Improvement Committee. The project was undertaken
as an effort in Continuing Quality Improvement (CQI) of the
department's core process. The reporting back of the audit
results to the Operation Group and a follow-up, if necessary,
was an inherent part of the process. The results of the audit for
all three photon energies at the institution are well within the
IAEA/WHO acceptance limit of ±5%. Had it been otherwise,
an appropriate follow-up, in concert with and as
recommended by IAEA/WHO, would have been deemed
492

The calibration of megavoltage beams from linear
accelerators has three essential requirements: (i) the use of an
ion chamber with a calibration traceable to an SSDL; (ii) an
accurate experimental setup; and, (iii) the correct
interpretation of the dosimetry protocol to determine and
correctly apply the factors to convert the charge reading to the
absorbed dose in water at the calibration point.
The Pakistan Nuclear Regulatory Authority (PNRA)
requires that the ion chamber used for absolute dose
measurements be calibrated at SSDL every two years. Our
institution has been in compliance with this requirement
since its inception in February 2006. However, absolute
dose calibrations may still be prone to errors arising from an
incorrect setup and/or incorrect interpretation/application of
the dose measurement protocol. Hence, it would be
reassuring to have them verified by an independent external
facility. The IAEA/WHO TLD Audit Service provides just
such an opportunity.

Conclusion
Based on our experience, we recommend that all
cancer centres in Pakistan shall participate in the
IAEA/WHO-sponsored service to ensure an external
validation of their photon beam outputs.
J Pak Med Assoc

dosimetry as a tool for the remote verification of output for radiotherapy beams.
Proc Int Symp Standards and Codes of Practice in Med Rad Dosim. IAEA-CN96/82, IAEA (2002), 191-199.

Acknowledgements
The authors thankfully acknowledge the assistance of
the Medical Physics staff, radiation Oncology at the Aga
Khan University Hospital, Karachi.

References

9.

Ferreira, IH, Dutreix A, Bridier A, Chavaudra J, Svensson H. The Estro Quality
Assurance Network (EQUAL). Radiother Oncol 2000; 55: 273-84.

10.

Izewska J, Andreo P. The IAEA/WHO TLD postal programme for radiotherapy
hospitals. Radiother Oncol 2000; 54: 65-72.

11.

Scarantino CW, Rini CJ, Aquino M, Carrea TB, Ornitz RD, Anscher MS, et al.
Initial clinical results of an in-vivo dosimeter during external beam radiation
therapy. Int J Radia Oncol Biol Phys 2005; 62: 606-13.

12.

Briere TM, Tailor R, Tolani N, Prado K, Lane R, Woo S, et al. Patient dosimetry
for total body irradiation using single-use MOSFET detectors. Jour Appl Clin
Med Phys 2008; 9: 200-5.

1.

Report of Task Group 40: Comprehensive QA for radiation oncology. Med
Phys1994; 21: 581-619.

2.

Thwaites DI. Quality assurance in radiotherapy. Radiother Oncol 1995; 35: 61-73.

3.

Physics aspects of quality control in radiotherapy, edited by Mayles WPM et al.
York, United Kingdom: IPEM, 1999; Report 81.

4.

Podgorasak, EB. Review of radiation oncology physics: a handbook for
teachers and students. Educational Report Series. Vienna, Austria: International
Atomic Energy Agency, 2003.

13.

Joanna Izewska, TLD Officer, Dosimetry and Medical Radiation Physics
Section, Division of Human Health, IAEA, Wagramer Strasse 5, P. O. Box 100,
A-1400 Vienna, Austria.

5.

Secondary Standards Dosimetry Laboratory, Health Physics Division,
Pakistan Institute of Nuclear Science & Technology, P. O. Nilore,
Islamabad, Pakistan.

14.

Principles of operation of the IAEA/WHO TLD postal dose audit service for
radiotherapy centres. Vienna, Austria: International Atomic Energy Agency;
2010 June. SSDL Newsletter No. 58.

6.

IAEA/WHO Network of Secondary Standards Laboratories. Vienna, Austria:
International Atomic Energy Agency; 2010 June. SSDL Newsletter No. 58.

15.

Izewska J, Hulqvist M, Bera P. Analysis of uncertainties in the IAEA/WHOTLD
postal audit system. Rad Meas 2008; 43: 959-63.

7.

AAPM's TG-51 protocol for clinical reference dosimetry of high-energy photon
and electron beams. Med Phys 1999; 26: 1847-70.

16.

8.

Aguire JF, Tailor R, Ibbot G, Stovall M, Hanson W. Thermoluminescent

Absorbed Dose Determination in External Beam Radiotherapy: An
International Code of Practice for Dosimetry based on Standards of Absorbed
Dose to Water. Vienna: IAEA TRS-398, IAEA, 2000; ISSN 1011-4289.

Vol. 62, No. 5, May 2012

493

